TFRC and breast cancer: Transferrin receptor 1 (TFR1), an independent prognostic factor, is positively related to the amounts of immune cells (CD8+ T cells, CD4+ T cells, neutrophils, B cells, macrophages, and dendritic cells) in breast cancer patients (Chen F. et al., 2021).